Ph.D. in Diabetology is a 3-5 year research-intensive program devoted to the study of diabetes mellitus, its pathogenesis, and novel treatment options. The program combines endocrinology, molecular biology, clinical medicine, and public health to investigate the origins, treatment, and prevention of Type 1 and Type 2 diabetes. Students do research on insulin resistance, glucose metabolism, diabetic complications, and the development of novel therapeutics such as gene therapy and personalized medicine. Graduates learn about clinical trials, data analysis, and diabetes-related healthcare policies. Career prospects include academic research, clinical practice, healthcare facilities, and the pharmaceutical business, which contribute to breakthroughs in diabetes care and prevention.